Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Takeda to Start Joint Drug Discovery with Albany Molecular Research
December 9, 2002
- Kyowa Hakko: R&D Spending to Reach 19.3% of Sales in FY2002
December 2, 2002
- BUSINESS NEWS IN BRIEF
December 2, 2002
- Mitsubishi Chemical Corp: Healthcare Sales Up 115.2%
December 2, 2002
- NEW PRODUCTS
December 2, 2002
- Kirin Brewery: Drug Sales Up to \35.5 Bil. in First 3 Quarters
December 2, 2002
- Bill for New Drug Organization Passes Lower House
December 2, 2002
- Yakult: Semiannual Drug Sales Up 39% Due to Campto
December 2, 2002
- JMA Proposes Step-wise Integration of Health Insurance Programs
December 2, 2002
- CMIC: Annual Sales, Profits Increase Sharply
December 2, 2002
- Korosho to Create Database to Identify Similar Drugs
December 2, 2002
- ARKRAY to Push Healthcare Products Business
December 2, 2002
- Major Wholesalers Report Large Increases in Profits
December 2, 2002
- REGULATORY NEWS IN BRIEF
December 2, 2002
- Meet the Leaders (12)
December 2, 2002
- Kuraya Sanseido: Sales Up 3.8%, Profits Up 254.6%
December 2, 2002
- Olympus: Medical Systems Group Sales Up 9.3% to \127 Bil.
December 2, 2002
- Santen: Sales Up 6.1%, but Profits Down 41.6%
December 2, 2002
- Suzuken: Expansion of Pharmacy Market Drives Sales, Profits
December 2, 2002
- MEDICAL DEVICE NEWS IN BRIEF
December 2, 2002
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…